U.S. COVID vaccines, treatments to be moved from governement to commercial markets in 2023

U.S. plans to move COVID vaccines, treatments to private markets in 2023 The U.S. government expects its supply of COVID-19 vaccines and antiviral treatments to run out over the next year and is preparing for them to be sold via the commercial market, the Department of Health and Human Services said on Tuesday. Ahmed Aboulenein Reuters

...

The administration has procured enough of Pfizer's (PFE.N) antiviral treatment Paxlovid to supply the pills until mid-2023, O'Connell said, but other therapeutics made by Merck & Co (MRK.N) and AstraZeneca (AZN.L) are likely to be sold on the commercial market sooner.

"Our goal is to transition procurement and distribution of COVID-19 vaccines and therapeutics from a federally managed system to the commercial marketplace in a thoughtful, well-coordinated manner that leaves no one behind," she wrote following a meeting with private sector representatives.

...